Administration of recombinant human adenovirus-p53 (rAd-p5\Gendicine) in HCC significantly upregulated FBXW7 and downregulated its substrates c-Myc and cyclin E, resulting in the inhibition of cellular growth and apoptosis in vitro and in vivo [142]. The gene discussed is TP53; the disease is hepatocellular carcinoma.